The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore, and another Rs 14,000-crore investment from about 50 multinational companies.
Multinational organizations including PepsiCo and industry associations like IPA, have come in favour of India's intellectual property regime, which is being reviewed by the US administration.
India will export anti-malarial drug hydroxychloroquine, high in demand globally, only to foreign governments and not to private companies, as the product is under prohibited or banned category of exports, sources said. Although exports of this medicine is completely banned, India has decided to export this anti-malarial drug in sync with its global commitment to deal with the coronavirus pandemic.
Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.
The honour acknowledges the potential of India as a book reading nation and underlines its growing importance in making the Asia Pacific region a book reading society.
Snooping is one of the oldest peccadilloes of man, observes Ambassador M K Bhadrakumar.
The government regulates prices of all other medicines.
The successful implementation of the new Act will depend on a much bigger involvement of the state through a huge new superstructure of registration, certification and supervision
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
Under the current administration, political attitudes toward IP seem to have improved.
A federal body began a hearing on the impact of Indian trade policies on US businesses wherein American bodies and advocacy groups slammed India for its trade practices, alleging they hit their jobs and business.
'The hour is very late, and the choice between triumph and tragedy knocks at our door,' says Ajay Shah.
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
''There is the perennial worry in the Indian mind regarding the US 'hyphenating' India and Pakistan. Frankly, this is a completely nonsensical hypothesis. The US has always 'hyphenated' India and Pakistan and it couldn't have been otherwise,' says Ambassador M K Bhadrakumar.
